GC Green Cross Launches In-House Developed Acne Treatment 'AzelaHill Cream'

On October 6, GC Green Cross announced the launch of "AzelaHill Cream," an azelaic acid-based acne treatment that the company developed and manufactures in-house.

Product image of GC Green Cross' Azela Heal Cream. GC Green Cross

AzelaHill Cream is an over-the-counter medication containing azelaic acid, a proprietary ingredient developed by GC Green Cross. In July, the product received item approval, marking the first time a domestic pharmaceutical company has secured such authorization in Korea.

The main ingredient of AzelaHill Cream, azelaic acid, is widely used for acne treatment and is included in acne treatment guidelines not only in Korea, but also in the United States, Europe, and Japan. It is effective for various types of acne, including inflammatory acne, whiteheads, and blackheads.

AzelaHill Cream is packaged in a laminate tube, enhancing the cream’s application and texture. With this launch, consumer choice in the domestic azelaic acid acne treatment market—which previously centered on imported products—is expected to broaden.

Jae-Eun Jung, Brand Manager at GC Green Cross, stated, "AzelaHill Cream was developed not only with product efficacy in mind, but also for user convenience," adding, "Starting this year, we will actively conduct consumer advertising to raise brand awareness and establish AzelaHill Cream as a new option for acne treatment."

This content was produced with the assistance of AI translation services.